AKT1 and prostate carcinoma: found that α‐tomatine inhibits the PI3K/AKT signaling pathway, up‐regulates the pro‐apoptotic protein BAD, and down‐regulates the anti‐apoptotic proteins Bcl‐2/xL, as well as having a synergistic effect with paclitaxel to inhibit prostate cancer.